2575.HK · XUANZHUBIO-B
Hong Kong · RS rating 7 · As of 2026-11-03
| Price | 8.11 HKD |
|---|---|
| 1-day change | +4.8% |
| RS rating (overall / 1M / 3M / 12M) | 7 / 44 / 13 / 3 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 25 / 8 / 9 |
| Industry group (rank) | Pharma & Biotech (27) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +90.2% |
| Market cap (USD) | $567.7M |